Authorisation and commercialisation of microbial biopesticides: regulatory innovation and the regulatory state
暂无分享,去创建一个
Agriculture faces a serious challenge to develop sustainable pest management systems. Microbial biopesticides can make important contributions to IPM, but their commercialisation is affected strongly by the regulatory system that governs their authorisation. This occurs no more so than in the European Union, where arrangements for microbial agents are complex and operate separately at national and EU-wide levels. It is widely accepted that the current system needs to improve. Although there is a strong role for government in helping new industries that bring positive public benefits, the regulatory authority has a difficult job to ensure product quality and public safety while not inhibiting commercialisation. We have been investigating the prospects for regulatory innovation for microbial biopesticides in the UK, although our work is relevant
generally. We have used, as a starting point, the debate about Weberian bureaucratic theory and Moran’s theory of The Regulatory State combined with empirical research based on interviews with key actors and a comparison of arrangements in the EU and US. We have developed a set of regulatory design principles that we hope can be used to guide regulators and practitioners to achieve more
innovation for the commercialisation and authorisation of microbial pest control agents